Developing a conceptual framework to improve understanding of AMR in livestock systems: translating research into policy and practice
Lead Research Organisation:
UNIVERSITY OF EXETER
Department Name: Institute of Biomed & Clinical Science
Abstract
It is estimated that by 2050 AMR infections will be the leading cause of death globally with a total economic cost of $100 trillion, with the overwhelming burden placed on LMICs (O'Neill report, 2016). Antimicrobial usage (AMU) in livestock has been shown to be an important driver of antimicrobial resistance (AMR) in animals and is associated with resistance in the clinical setting, with a recent review attributing 24% of AMR in humans to AMU in animals. Impacts on the wider environment are also well documented as is the potential for human exposure and transmission; although the latter are poorly quantified for livestock rearing scenarios. Agriculture's share of global antibiotic consumption is high and rising, as the demand for animal protein increases, especially in low and middle-income countries. Without considering the important role that the farmed and natural environment plays in contributing to the overall burden of AMR infection, and taking steps to reduce environmental AMR, efforts in other sectors may not prevent the post-antibiotic era that threatens modern medicine. We will consider the issue of AMR using a DPSEEA framework (Drivers-Pressure-State- Exposure-Effect-Action). This framework was designed to allow complex problems to be broken down into logical components, it also allows Actions and critical control points to be identified which lends itself to the application of control theory modelling approaches. We will produce a "blueprint" for an integrated surveillance, analysis, interpretation, modelling and policy translation approach that can be utilised for any livestock system in any LMIC to facilitate decision making, implementation of incentives and informing new policy around interventions to reduce AMU, AMR and risk to human health. This will reduce the economic and societal burden of AMR whilst ensuring associated economic costs of interventions are considered.
Rather than trying to generate as much surveillance data, in as many livestock rearing systems, under as many management strategies as possible, we have instead taken an interdisciplinary approach to studying the impacts of feedlot production on antimicrobial usage and AMR in beef cattle as well as feedlot impacted environments. The rationale being that we can investigate this single livestock system, as an exemplar, in detail, including the impacts of cattle breeding and rearing systems combined with specific interventions including reduction of use of antibiotics as growth promoters, cessation of metaphylaxis at the point of recruitment to the feedlot and vaccination as an additional intervention. The use of dairy sourced calves as an additional risk factor due to increased antimicrobial usage (AMU) on dairy farms will also be investigated. Feedlot beef production is increasingly used instead of grassland production in much of Latin America and other parts of the world including LMICs in Latin America and beyond. It is ironic that as international efforts to tackle AMR increase (eg. the FAO, OIE and WHO Memorandum of Understanding, signed on the 30 May 2018) one of the remaining largely extensive, low AMU livestock systems is moving towards intensive, high AMU production systems. The impacts of this will be felt most keenly in LMICs where demand is increasingly most rapidly for affordable animal protein.
Rather than trying to generate as much surveillance data, in as many livestock rearing systems, under as many management strategies as possible, we have instead taken an interdisciplinary approach to studying the impacts of feedlot production on antimicrobial usage and AMR in beef cattle as well as feedlot impacted environments. The rationale being that we can investigate this single livestock system, as an exemplar, in detail, including the impacts of cattle breeding and rearing systems combined with specific interventions including reduction of use of antibiotics as growth promoters, cessation of metaphylaxis at the point of recruitment to the feedlot and vaccination as an additional intervention. The use of dairy sourced calves as an additional risk factor due to increased antimicrobial usage (AMU) on dairy farms will also be investigated. Feedlot beef production is increasingly used instead of grassland production in much of Latin America and other parts of the world including LMICs in Latin America and beyond. It is ironic that as international efforts to tackle AMR increase (eg. the FAO, OIE and WHO Memorandum of Understanding, signed on the 30 May 2018) one of the remaining largely extensive, low AMU livestock systems is moving towards intensive, high AMU production systems. The impacts of this will be felt most keenly in LMICs where demand is increasingly most rapidly for affordable animal protein.
Technical Summary
The project aims to generate new ways of considering AMR in farmed and natural environments, focusing on a Driving Force-Pressure-State-Exposure-Effect-Action (DPSEEA) framework to explore the linkages between selection for and dissemination of antimicrobial resistance (AMR) and the processes that drive this phenomenon. We will focus on feedlot beef production systems, as an exemplar, which are increasingly being used in Argentina and low and middle income countries (LMICs) in Latin America to replace less intensive, grass fed, low antimicrobial usage (AMU) systems. With thousands of animals kept within small areas large amounts of manure are generated which can impact surrounding soil and water resources with the potential for wider dissemination and risk of human exposure and environmental transmission of AMR pathogens. The research consortium is made up of AMR experts from Argentina and the UK, from government institutions and universities and includes clinical, veterinary and environmental microbiologists, specialists in bioinformatics and genomics, agricultural economics, evidence synthesis, mathematical modelling and AMR policy. This interdisciplinary team will enable a holistic approach to the problem, integrating understanding of 1) economic and human behaviours that drive AMU and livestock management practice, 2) evolutionary and ecological processes that lead to increased AMR in animal faeces and environmental matrices such as soil and water 3) mechanistic insights into resistance mechanisms and evolution of resistance within impacted environments and 4) human exposure risk associated with environmental and food borne human exposure. This data will be used to populate the conceptual framework, highlighting where knowledge gaps exist, and in development of an underpinning mathematical model using critical control, info-gap and adaptive management theories.
Planned Impact
The proposed research will make an important contribution to efforts to tackle AMR within Argentina, other LMICs and in a global context. We will produce a "blueprint" for an integrated surveillance, analysis, interpretation, modelling and policy translation approach that can be used in any livestock system in any LMIC to facilitate decision making, implementation of incentives and inform new policy around interventions to reduce AMU, AMR and risk to human health. This will reduce the economic and societal burden of AMR whilst ensuring associated economic costs of interventions are considered. We will focus on beef feedlot systems as they pose an emerging threat through increased antimicrobial usage, relative to conventional grassland production systems, and the potential for environmental contamination from large amounts of waste. The research project will benefit livestock producers by identifying the most cost-effective mitigation
strategies to reduce AMR and will benefit consumers and society by reducing the risk of human AMR infection. The project will also benefit researchers studying AMR as we will investigate new ways of thinking about AMR in a holistic way, and will ensure impact through engagement with policy makers through a dedicated policy work package and through knowledge exchange via an extensive network of contacts throughout the world including the WHO, OIE, FAO and UNEP who lead the Tripartite Plus response to AMR.
strategies to reduce AMR and will benefit consumers and society by reducing the risk of human AMR infection. The project will also benefit researchers studying AMR as we will investigate new ways of thinking about AMR in a holistic way, and will ensure impact through engagement with policy makers through a dedicated policy work package and through knowledge exchange via an extensive network of contacts throughout the world including the WHO, OIE, FAO and UNEP who lead the Tripartite Plus response to AMR.
Publications


EFSA Panel on Biological Hazards (BIOHAZ)
(2021)
Role played by the environment in the emergence and spread of antimicrobial resistance (AMR) through the food chain.
in EFSA journal. European Food Safety Authority

Larsson DGJ
(2023)
AMR, One Health and the environment.
in Nature microbiology

Manaia C
(2020)
Antibiotic Resistance in the Environment - A Worldwide Overview

Redman-White C
(2023)
A review of the predictors of antimicrobial use and resistance in European food animal production
in Frontiers in Antibiotics

Stanton IC
(2022)
Existing evidence on antibiotic resistance exposure and transmission to humans from the environment: a systematic map.
in Environmental evidence
Description | We have conducted a systematic review which demonstrates the relationship between AMR and AMU in feed feedlot systems with differences between injectable and in feed antibiotics on AMR load in faeces. |
Exploitation Route | Informing antibiotic prescribing practice |
Sectors | Agriculture Food and Drink Environment |
Description | The framework which underpins this grant proposal has been requested by Wellcome and WHO and my presentation at EDAR 5 has resulted in further work with WHO on risk assessment tools for AMR and environment |
First Year Of Impact | 2019 |
Sector | Agriculture, Food and Drink,Healthcare |
Impact Types | Policy & public services |
Description | ? Participated in Epi-Net meeting Dec 3rd 2021. |
Geographic Reach | Europe |
Policy Influence Type | Membership of a guideline committee |
Impact | Will determine future AMR surveillance policy and practice on Europe |
Description | Advised European Bank for Reconstruction and Development on AMR |
Geographic Reach | Europe |
Policy Influence Type | Contribution to new or improved professional practice |
Impact | Advised European Bank for Reconstruction and Development on AMR |
Description | Advising Deloitte on evaluation of the UK gov AMR surevillance programme PATH-SAFE |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | Informing national policy |
Description | Consulting for DG Sante on AMR policy |
Geographic Reach | Europe |
Policy Influence Type | Contribution to a national consultation/review |
Impact | Informing EU policy |
Description | Gave evidence to Defra on AMR and ENvironment |
Geographic Reach | National |
Policy Influence Type | Contribution to a national consultation/review |
Description | Held KE meeting at the University of Exeter attended by ES, Defra, Welsh and NI devolved governments, water industry, clinicians etc |
Geographic Reach | National |
Policy Influence Type | Membership of a guideline committee |
Description | Invited by British Society of Antimicrobial Chemotherapy to contribute to discussion around new AMR National Action Plan. One of a small number of academics to be invited. |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Invited to participate in Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC) Genomic Surveillance of Antimicrobial Resistance working group workshop lead by Professor Kate Baker, Dr Elita Jauneikaite, Professor Sharon Peacock and Professor Nicholas Feasey. |
Geographic Reach | Europe |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | NA |
Description | Member of UK AMR NAP Stakeholder group |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | iNFORMING NATIONAL HEALTH POLICY |
Description | We are currently involved in five AMR PATH-SAFE contracts in collaboration with UKCEH on three contracts and WSP on one contract |
Amount | £200,000 (GBP) |
Organisation | Environment Agency |
Sector | Public |
Country | United Kingdom |
Start | 08/2022 |
End | 03/2023 |
Description | Supervising EA staff member for postgraduate degree on environmental AMR surveillacne |
Organisation | Environment Agency |
Country | United Kingdom |
Sector | Public |
PI Contribution | We have supervised the EA staff member who works on the UKHSA?FSA/EA PATH-SAFE AMR surveillance programme |
Collaborator Contribution | Research student |
Impact | Will inform EA AMR surevillance strategy |
Start Year | 2022 |
Description | Working with UKCEH on PATH-SAFE projects |
Organisation | UK Centre for Ecology & Hydrology |
Country | United Kingdom |
Sector | Public |
PI Contribution | We have jointly bid and are delivering three contracts on AMR for the Environment Agency through PATH-SAFE |
Collaborator Contribution | Joint delivery of three contracts |
Impact | Three reports which may lead to publications |
Start Year | 2022 |
Description | ? Presented to the APPG on Antibiotics with report generated requestruing AMR be included in the new Environment Bill |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | Myself, Aimee Murray and Isobel Stanton gave evidence to the APPG on Antibiotics, highlighting the importance of the environmental dimension of AMR. We presented evidence that should inform the environment bill which is currently at amendment stage. |
Year(s) Of Engagement Activity | 2020 |
Description | Advising European Bank for Reconstruction and Development Bank on their Environment and Social Policy regarding AMR |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Talk about AMR to the investment community |
Year(s) Of Engagement Activity | 2023 |
Description | Attended AstraZeneca meeting on pharmaceutical contaminants in LMICs in Nairobi |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Industry/Business |
Results and Impact | I led a working group on AMR and environment, considering the issue from a LMIC perspective |
Year(s) Of Engagement Activity | 2019 |
Description | Contributed to Aviva Investors report on AMR, biodiversity loss and climate change |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation of report at Aviva Investors, London |
Year(s) Of Engagement Activity | 2022 |
URL | https://www.avivainvestors.com/en-gb/views/aiq-investment-thinking/2022/11/antimicrobial-resistance/ |
Description | HCWH webinar with myself and Dame Sally Davies, I hr to journalists and other specialists eg. WHO. |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Policymakers/politicians |
Results and Impact | Webinar with myself and Dame Sally Davies answering questions from policy makers and media around AMR |
Year(s) Of Engagement Activity | 2019 |
Description | Invited speaker UK:Russia AMR roundtable, Nov 23rd organised by BSAC. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | ~30 AMR specialists from the UK and Russia discussing potential collaborations, coordinated by the British Society for Antimicrobial Chemotherapy. |
Year(s) Of Engagement Activity | 2021 |
Description | Keynote speaker at the Environmental Dimension of Antibiotic Resistance conference in Hong Kong in June 2019 |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | This was an international conference attended by academics and representatives from Wellcome, WHO and UNEP. I presented the theoretical framework which underpins this project grant and it was well received with both Wellcome and WHO requesting a copy of my presentation. |
Year(s) Of Engagement Activity | 2019 |
Description | Quadripartitie one health priority research agenda for antimicrobial resistance |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Policymakers/politicians |
Results and Impact | Contributed towards the report, sitting on a panel of experts who contributed to teh report |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.who.int/publications/i/item/9789240075924 |